跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FINOMEL 1820mL intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion) - TGA Drug Approval Details
Approvals
/
TGA
/
FINOMEL 1820mL intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion)
Approved
STANDARD
FINOMEL 1820mL intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion)
Baxter Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0c71adf49c9c818f
Company
Baxter Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
0c71adf49c9c818f
Product Name
FINOMEL 1820mL intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion)
Artg Id
307363
Artg Name
FINOMEL 1820mL intravenous infusion bag (10% amino acid with electrolyte 42% glucose and 20% lipid emulsion)
Sponsor
Baxter Healthcare Pty Ltd
Company Detail Path
/organization/baxter-healthcare-pty-ltd
Artg Date
2019-06-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01852-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0c71adf49c9c818f
Type
Standard
Back to TGA Approvals